Metabolite

KNApSAcK Entry

id C00005818
Name Icariside II / Baohuoside 1 / 3-[(6-Deoxy-alpha-L-mannopyranosyl)oxy]-5,7-dihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one
CAS RN 113558-15-9
Standard InChI InChI=1S/C27H30O10/c1-12(2)5-10-16-17(28)11-18(29)19-21(31)26(37-27-23(33)22(32)20(30)13(3)35-27)24(36-25(16)19)14-6-8-15(34-4)9-7-14/h5-9,11,13,20,22-23,27-30,32-33H,10H2,1-4H3/t13?,20-,22?,23-,27-/m0/s1
Standard InChI (Main Layer) InChI=1S/C27H30O10/c1-12(2)5-10-16-17(28)11-18(29)19-21(31)26(37-27-23(33)22(32)20(30)13(3)35-27)24(36-25(16)19)14-6-8-15(34-4)9-7-14/h5-9,11,13,20,22-23,27-30,32-33H,10H2,1-4H3

Cluster

Phytochemical cluster
KCF-S cluster No. 371

Link

ChEMBL

By standard InChI
By standard InChI Main Layer CHEMBL497293 CHEMBL560116

KEGG

By LinkDB

CTD

By CAS RN C060988

Human Protein / Gene in interaction

2 ChEMBL Protein in interactions

accession description class description compound assay ID (# of activities) # of diseases
(OMIM / KEGG)
O76074 cGMP-specific 3',5'-cyclic phosphodiesterase PDE_5A CHEMBL497293 CHEMBL998833 (1)
0 / 0
P51160 Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' PDE_6C CHEMBL497293 CHEMBL998836 (1)
1 / 1

CTD interaction (15)

compound gene gene name gene description interaction interaction type form reference
pmid
C060988 581 BAX
BCL2L4
BCL2-associated X protein baohuoside I results in increased expression of BAX protein increases expression
protein 22687635
C060988 596 BCL2
Bcl-2
PPP1R50
B-cell CLL/lymphoma 2 baohuoside I results in decreased expression of BCL2 protein decreases expression
protein 22687635
C060988 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) baohuoside I results in increased activity of CASP3 protein increases activity
protein 19289254
C060988 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) baohuoside I results in increased cleavage of CASP3 protein increases cleavage
protein 22687635
C060988 841 CASP8
ALPS2B
CAP4
Casp-8
FLICE
MACH
MCH5
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) baohuoside I results in increased activity of CASP8 protein increases activity
protein 19289254
C060988 842 CASP9
APAF-3
APAF3
ICE-LAP6
MCH6
PPP1R56
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) baohuoside I results in increased activity of CASP9 protein increases activity
protein 19289254
C060988 842 CASP9
APAF-3
APAF3
ICE-LAP6
MCH6
PPP1R56
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) baohuoside I results in increased cleavage of CASP9 protein increases cleavage
protein 22687635
C060988 4843 NOS2
HEP-NOS
INOS
NOS
NOS2A
nitric oxide synthase 2, inducible (EC:1.14.13.39) baohuoside I results in decreased expression of NOS2 decreases expression
19289254
C060988 142 PARP1
ADPRT
ADPRT_1
ADPRT1
ARTD1
PARP
PARP-1
PPOL
pADPRT-1
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) baohuoside I results in increased cleavage of PARP1 protein increases cleavage
protein 19289254
22687635
C060988 142 PARP1
ADPRT
ADPRT_1
ADPRT1
ARTD1
PARP
PARP-1
PPOL
pADPRT-1
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) Dinoprostone inhibits the reaction [baohuoside I results in increased cleavage of PARP1 protein] decreases reaction
/ increases cleavage
protein 19289254
C060988 142 PARP1
ADPRT
ADPRT_1
ADPRT1
ARTD1
PARP
PARP-1
PPOL
pADPRT-1
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) PTGS2 mutant form promotes the reaction [baohuoside I results in increased cleavage of PARP1 protein] increases cleavage
/ increases reaction
protein 19289254
C060988 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) baohuoside I results in decreased expression of PTGS2 decreases expression
19289254
C060988 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) [baohuoside I results in decreased expression of PTGS2] which results in decreased abundance of Dinoprostone decreases abundance
/ decreases expression
19289254
C060988 5743 PTGS2
COX-2
COX2
GRIPGHS
PGG/HS
PGHS-2
PHS-2
hCox-2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) PTGS2 mutant form promotes the reaction [baohuoside I results in increased cleavage of PARP1 protein] increases cleavage
/ increases reaction
mutant form 19289254
C060988 7422 VEGFA
MVCD1
VEGF
VPF
vascular endothelial growth factor A baohuoside I results in decreased expression of VEGFA decreases expression
19289254

Related Disease

Diseases related to proteins in ChEMBL interactions

OMIM (1)

OMIM preferred title UniProt
#613093 Cone dystrophy 4; cod4 P51160

KEGG DISEASE (1)

KEGG disease name UniProt
H00481 Cone-rod dystrophy and cone dystrophy P51160 (related)